Viokase 16    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
298Hereditary pancreatitis2

298. Hereditary pancreatitis    [ 93 clinical trials,   168 drugs,   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways]
Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 93 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01142128
(ClinicalTrials.gov)
February 20099/6/2010Viokase 16, Viokase16 Plus Nexium and Nexium AloneA Randomized, Single Site, Double Blind, Fixed Dose, Cross Over Study of Viokase 16, Viokase16 Plus Nexium and Nexium Alone in the Reduction of Abdominal Pain in Patients With Chronic PancreatitisChronic PancreatitisDrug: Nexium (esomeprazole magnesium);Drug: Placebo to Nexium;Drug: Viokase 16 (pancrelipase) + Nexium;Drug: Viokase 16 + placebo to NexiumUniversity of FloridaAstraZenecaTerminated18 Years75 YearsAll12Phase 1United States
2NCT00559052
(ClinicalTrials.gov)
March 200814/11/2007An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)An Open-Label Cross-over Study to Evaluate the Intraduodenal Delivery of Lipase, Protease and Amylase From Administration of VIOKASE16 in Chronic Pancreatitis Subjects With Exocrine Pancreatic Insufficiency (EPI).Exocrine Pancreatic InsufficiencyDrug: VIOKASE 16Axcan PharmaAAIPharma;Mayo Clinical Services;City Hospital Laboratory BirminghamCompleted18 YearsN/ABoth22Phase 2United States;Czech Republic